290 related articles for article (PubMed ID: 21533822)
1. Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
Sargent DJ; Resnick MB; Meyers MO; Goldar-Najafi A; Clancy T; Gill S; Siemons GO; Shi Q; Bot BM; Wu TT; Beaudry G; Haince JF; Fradet Y
Ann Surg Oncol; 2011 Nov; 18(12):3261-70. PubMed ID: 21533822
[TBL] [Abstract][Full Text] [Related]
2. Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.
Sargent DJ; Shi Q; Gill S; Louvet C; Everson RB; Kellner U; Clancy TE; Pipas JM; Resnick MB; Meyers MO; Wu TT; Huntsman D; Validire P; Farooq U; Pavey ES; Beaudry G; Haince JF; Fradet Y
Clin Cancer Res; 2014 Aug; 20(16):4361-9. PubMed ID: 24919572
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
[TBL] [Abstract][Full Text] [Related]
4. Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.
Beaulieu M; Desaulniers M; Bertrand N; Deschesnes RG; Beaudry G; Garon G; Haince JF; Houde M; Holzer TJ
Diagn Mol Pathol; 2010 Mar; 19(1):20-7. PubMed ID: 20186008
[TBL] [Abstract][Full Text] [Related]
5. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
6. Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodes.
Haince JF; Houde M; Beaudry G; L'espérance S; Garon G; Desaulniers M; Hafer LJ; Heald JI; Lyle S; Grossman SR; Têtu B; Sargent DJ; Fradet Y
J Clin Pathol; 2010 Jun; 63(6):530-7. PubMed ID: 20498026
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma.
Lee HY; Choi HJ; Park KJ; Shin JS; Kwon HC; Roh MS; Kim C
Ann Surg Oncol; 2007 May; 14(5):1712-7. PubMed ID: 17253102
[TBL] [Abstract][Full Text] [Related]
8. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
Schulz S; Hyslop T; Haaf J; Bonaccorso C; Nielsen K; Witek ME; Birbe R; Palazzo J; Weinberg D; Waldman SA
Clin Cancer Res; 2006 Aug; 12(15):4545-52. PubMed ID: 16899600
[TBL] [Abstract][Full Text] [Related]
9. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.
Gray RG; Quirke P; Handley K; Lopatin M; Magill L; Baehner FL; Beaumont C; Clark-Langone KM; Yoshizawa CN; Lee M; Watson D; Shak S; Kerr DJ
J Clin Oncol; 2011 Dec; 29(35):4611-9. PubMed ID: 22067390
[TBL] [Abstract][Full Text] [Related]
10. Lymph node ratio: role in the staging of node-positive colon cancer.
Wang J; Hassett JM; Dayton MT; Kulaylat MN
Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
[TBL] [Abstract][Full Text] [Related]
11. Factors predicting oncologic outcomes in patients with fewer than 12 lymph nodes retrieved after curative resection for colon cancer.
Huh JW; Kim CH; Kim HR; Kim YJ
J Surg Oncol; 2012 Feb; 105(2):125-9. PubMed ID: 21837680
[TBL] [Abstract][Full Text] [Related]
12. Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer.
Mescoli C; Albertoni L; Pucciarelli S; Giacomelli L; Russo VM; Fassan M; Nitti D; Rugge M
J Clin Oncol; 2012 Mar; 30(9):965-71. PubMed ID: 22355061
[TBL] [Abstract][Full Text] [Related]
13. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
[TBL] [Abstract][Full Text] [Related]
14. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
[TBL] [Abstract][Full Text] [Related]
15. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.
Berger AC; Sigurdson ER; LeVoyer T; Hanlon A; Mayer RJ; Macdonald JS; Catalano PJ; Haller DG
J Clin Oncol; 2005 Dec; 23(34):8706-12. PubMed ID: 16314630
[TBL] [Abstract][Full Text] [Related]
16. Nodal stage of stage III colon cancer: the impact of metastatic lymph node ratio.
Park IJ; Choi GS; Jun SH
J Surg Oncol; 2009 Sep; 100(3):240-3. PubMed ID: 19330780
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of lymph node ratio and location of nodal involvement in patients with right colon cancer.
Kobayashi H; Enomoto M; Higuchi T; Uetake H; Iida S; Ishikawa T; Ishiguro M; Kato S; Sugihara K
Dig Surg; 2011; 28(3):190-7. PubMed ID: 21555889
[TBL] [Abstract][Full Text] [Related]
18. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
19. Lymph node evaluation of colon cancer and its association with improved staging and survival in the Department of Defense Health Care System.
Lee S; Hofmann LJ; Davis KG; Waddell BE
Ann Surg Oncol; 2009 Nov; 16(11):3080-6. PubMed ID: 19636635
[TBL] [Abstract][Full Text] [Related]
20. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer.
Law CH; Wright FC; Rapanos T; Alzahrani M; Hanna SS; Khalifa M; Smith AJ
J Surg Oncol; 2003 Nov; 84(3):120-6. PubMed ID: 14598354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
